Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The global renal biomarkers market was valued at USD 1044.64 Million in 2025 driven by the rising incidence of kidney diseases across the globe. The market is anticipated to grow at a CAGR of 7.65% during the forecast period 2026-2035 to reach a value of USD 2183.27 Million by 2035.
Q1 2026 Market Updates
Geopolitical Impact of Iran, US, and Israel War on the Renal Biomarkers Market
United States: The Renal Biomarkers Market, a key segment of the global economy, is experiencing a complex operating environment in Q1 2026 as a direct consequence of the US-Israel-Iran war. Petrochemical-derived pharmaceutical packaging materials including blister packs, polymer bottles, and specialty film coatings are facing 15-20% cost inflation from the Gulf supply disruption. API production costs are rising as petrochemical reagent prices increase 15-20%. Air freight costs have spiked dramatically, with temperature-sensitive pharmaceutical distribution facing elevated costs and extended lead times as Gulf carrier networks remain suspended. Consumer spending caution is growing as gasoline above USD 4 per gallon and 4.2% projected inflation compress household discretionary budgets. Clinical trial operations in Middle Eastern investigator sites have been disrupted, and medical supply chains face elevated logistics costs.
Iran: Iran's healthcare system has been severely damaged by the conflict, with the WHO identifying at least 13 health facilities as conflict-damaged. The domestic pharmaceutical and medical device sector, already severely constrained by sanctions limiting access to Western medical technology and APIs, has been further disrupted by power outages, workforce displacement, and the collapse of medical supply chain logistics. Iranian patients requiring treatment for renal biomarkers conditions face an acute access crisis, as hospital operations are redirected toward treating conflict casualties and basic medical supplies are running low.
Israel: Israel's pharmaceutical and medical device sector is operating under emergency conditions. Israeli hospitals have moved some operations underground, medical resources are being prioritised for conflict casualties, and elective and non-emergency healthcare consumption has declined. However, Israel's biopharmaceutical research base continues to operate, with several Israeli companies involved in novel treatment development for renal biomarkers indications. Post-conflict, Israel's healthcare system is expected to invest significantly in medical technology and pharmaceutical infrastructure restoration and capacity expansion.
Key Takeaways
Government
- Relevant health authorities should activate emergency pharmaceutical supply chain resilience protocols, ensuring that API and packaging material sourcing for essential renal biomarkers treatments is not concentrated in Gulf-adjacent supply chains exposed to maritime disruption.
- Regulatory agencies should fast-track review of treatment availability and consider emergency compassionate use extensions for patients in conflict-affected regions who face interruption to their standard of care.
- Governments should monitor petrochemical-derived pharmaceutical packaging cost inflation, ensuring that price increases remain within access thresholds for patients requiring ongoing renal biomarkers treatment.
Market
- Petrochemical-derived pharmaceutical packaging and API precursor costs are rising 15-20%, creating margin compression for renal biomarkers manufacturers in the near term, with limited ability to pass costs through in price-regulated markets.
- The conflict's disruption to clinical trial infrastructure in Middle Eastern sites may modestly delay regulatory submissions and new treatment launches that had enrolled patients from the region, though the structural market growth trajectory remains intact.
- Healthcare system demand for renal biomarkers treatment is fundamentally driven by disease burden and demographics rather than geopolitical events, providing strong structural insulation for the market's long-term growth trajectory.
Procurement
- Pharmaceutical procurement teams should build 90-day safety stock for essential renal biomarkers treatment drugs and biological agents, hedging against further pharmaceutical logistics cost increases and potential supply disruptions.
- API and excipient buyers should review single-source supplier risks for Gulf-adjacent petrochemical-derived pharmaceutical inputs, establishing secondary supply arrangements with non-Gulf origin manufacturers in India, China, and Europe.
- Hospital pharmacy procurement managers should review cold-chain logistics contracts for temperature-sensitive renal biomarkers therapeutics, ensuring that alternative air routing through non-conflict-zone hubs is available if Gulf carrier services remain suspended.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
Continuous research and development activities to explore new biomarkers for renal conditions are driving the market growth.
-
The rising prevalence of chronic kidney diseases (CKD) is contributing to the increasing demand for novel treatments, propelling market demand.
-
The efforts of research institutes and promising discoveries are bringing hope to the renal biomarker domain, boosting market value in the forecast period.
Compound Annual Growth Rate
7.65%
Value in USD Million
2026-2035
*this image is indicative*
Renal Biomarkers Market Overview
Biomarkers are used to perform diagnoses and prognoses of medical conditions to curate and develop effective treatments for the medical condition. Biomarkers can be lipids, proteins, microRNAs, proteomic patterns, genes, metabolites, or cells present on a urinalysis. Renal biomarkers are supposed to be used to enhance diagnosis and treatment approaches for renal diseases.
Renal Biomarkers Market Growth Drivers
Rising Research Activities Poised to Bring Therapeutic Solutions
A new study published in May 2024 revealed that researchers discovered a novel biomarker in renal cell carcinoma subtypes. The cancer type is a diverse category with more than 20 known subtypes. The discovery is poised to enhance the ability to accurately diagnose many renal cell carcinoma subtypes, including some of the rarest subtypes. The enhanced diagnostic accuracy is expected to bring personalised treatments, improving patient outcomes. The discovery may trigger more researchers and key players to conduct additional research to explore more about the biomarker, anticipating market development.
Additionally, in January 2024, a group of researchers at MIT and Yale University School of Medicine discovered a compound originally developed as a potential cancer treatment that can allegedly treat autosomal dominant polycystic kidney disease (ADPKD). The drug exploits kidney cyst cells’ vulnerability to oxidative stress, a state of imbalance between damaging free radicals and beneficial antioxidants. The promising research is expected to bring innovative diagnostic approaches and treatments to the market, driving market growth. With a growing demand for biomarkers that can enable the development of targeted therapies and personalised treatments for patients, such research initiatives aimed at improving patient outcomes will propel market value in the coming years.
Renal Biomarkers Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Renal Biomarkers Market Segmentation
The EMR’s report titled “Global Renal Biomarkers Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Biomarker Type
- Functional Biomarker
- Up-Regulated Proteins
- Others
Market Breakup by Technique
- Enzyme Linked Immunosorbent Assay
- Particle Enhanced Turbidimetric Immunoassay
- Calorimetric Assay
- Chemiluminescent Enzyme Immunoassay
- Liquid Chromatography Mass Spectrometry
Market Breakup by Application
- Diagnosis and Disease progression Monitoring
- Research Homecare
- Others
Market Breakup by End Users
- Diagnostic labs
- Outpatient Clinics
- Research Centers
- Hospitals
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Renal Biomarkers Market Share
Segmentation by Biomarker Type to Witness Substantial Growth
Based on biomarker type, the market is divided into functional biomarker, up-regulated proteins and others. These biomarkers play a critical role in diagnosing, monitoring, and managing kidney-related diseases. The segment dominance can be attributed to the continuous discoveries of new markers that allegedly enhance diagnostic accuracy and prognostic capabilities. The high reliance of healthcare professionals on the combination of biomarkers to enhance patient outcomes drives demand for personalised treatments, reducing the burden of renal diseases.
Diagnostic Labs are Expected to Dominate the Market Share by End Users
The market segment by end users includes diagnostic labs, outpatient clinics, research centers, hospitals, and others. Diagnostic labs are leading the market segment due to the rising number of biomarkers testing that takes place at diagnostic labs. It offers a wide range of biomarker tests that are used to diagnose various aspects of kidney diseases, contributing to increased market demand. Their expertise in handling complex diagnostic procedures ensures accurate results and makes them the preferred choice for renal biomarker testing, propelling market growth.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Renal Biomarkers Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Among these, North America dominates the market share due to the high prevalence of chronic kidney diseases (CKD) in the region. The CKD prevalence is probably high due to the rising incidence of other conditions such as diabetes and hypertension requiring effective, advanced diagnostic and monitoring tools. The presence of a robust healthcare infrastructure and the presence of prominent market players boost research, development, and innovation in the region, propelling market growth.
Leading players in the Renal Biomarkers Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott Laboratories
It is an American multinational company that develops and sells medical devices and healthcare products. The company is a global leader in diagnostic solutions and offers advanced laboratory systems and point-of-care testing products. Their diagnostics division includes immunoassays, clinical chemistry, hematology, and molecular diagnostics.
BioPorto Diagnostics AS
Copenhagen-based BioPorto is an in-vitro diagnostics company specializing in antibodies and assay development. The company is focused on developing compelling products to address unmet medical needs and tests that can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem.
F.Hoffmann-La Roche AG
Commonly known as Roche, it is a Swiss multinational holding healthcare company operating in pharmaceuticals and diagnostics. It is the fifth-largest pharmaceutical company in the world by revenue specialising in providing treatments for cancer globally.
Siemens Healthineers AG
It is a German multinational company focused on providing innovative healthcare solutions through advanced technologies and services. The company offers a comprehensive range of diagnostic solutions, including clinical chemistry, immunoassays, hematology, and molecular diagnostics.
Thermo Fisher Scientific Inc.
It is a life science and clinical research company. Thermo Fischer develops diagnostic tests and instruments that are used in clinical and industrial settings, like immunoassays, microbiology, and molecular diagnostics.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Q² Solutions Company, BioMerieux SA, Sphingotec GmbH, Enzo Life Sciences Inc., and Randox Laboratories Ltd.
Key Questions Answered in the Renal Biomarkers Market
- What was the global renal biomarkers market value in 2025?
- What is the global renal biomarkers market forecast outlook for 2026-2035?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on biomarker type?
- How is the market segmented based on technique?
- How is the market segmented based on application?
- Who are the end-users in the market?
- What are the major factors aiding the global renal biomarkers market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major global renal biomarkers market trends?
- Which application is expected to dominate the market?
- Which biomarker type will dominate the market share?
- Which technique will lead the market?
- Who are the key players involved in the global renal biomarkers market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Biomarker Type |
|
| Breakup by Technique |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share